Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC-ONC Study-A Single-Center, Blinded, Randomized Controlled Trial

Prognostic Comparison of Different Sensitivity Cardiac Troponin Assays in Stable Heart Failure

(2015) Justin L. Grodin et al.   AMERICAN JOURNAL OF MEDICINE

Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy

(2015) D. Cardinale et al.   CIRCULATION

Prognostic Implications of Low Level Cardiac Troponin Elevation Using High-Sensitivity Cardiac Troponin T

(2015) Jonathan Grinstein et al.   CLINICAL CARDIOLOGY

Estimation of age- and comorbidities-adjusted percentiles of high-sensitivity cardiac troponin T levels in the elderly

(2015) Nils Kuster et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Effect of Remote Ischemic Preconditioning on Kidney Injury Among High-Risk Patients Undergoing Cardiac Surgery

(2015) Alexander Zarbock et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of One-Cycle Remote Ischemic Preconditioning to Reduce Myocardial Injury During Percutaneous Coronary Intervention

(2014) Theodoros A. Zografos et al.   AMERICAN JOURNAL OF CARDIOLOGY

Limb Remote Ischemic Preconditioning Attenuates Lung Injury after Pulmonary Resection under Propofol–Remifentanil Anesthesia

(2014) Cai Li et al.   ANESTHESIOLOGY

Prognostic significance of elevated troponin in non-cardiac hospitalized patients: A systematic review and meta-analysis

(2014) Amna N. Ahmed et al.   ANNALS OF MEDICINE

Predictive value of high-sensitivity troponin-I for future adverse cardiovascular outcome in stable patients with type 2 diabetes mellitus

(2014) Kai-Hang Yiu et al.   Cardiovascular Diabetology

Cardiac troponin release following standard dose anthracycline-based adjuvant chemotherapy

(2014) S. Haney et al.   EUROPEAN HEART JOURNAL

Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial

(2014) Luciano Candilio et al.   HEART

High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease

(2014) Willibald Hochholzer et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Prevention of Anthracycline-Induced Cardiotoxicity

(2014) Pimprapa Vejpongsa et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Continuous Cardiac Troponin I Release in Fabry Disease

(2014) Andreas Feustel et al.   PLoS One

Existing cardiomyocytes generate cardiomyocytes at a low rate after birth in mice

(2014) S. R. Ali et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity

(2014) Laura Cove-Smith et al.   TOXICOLOGICAL SCIENCES

Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

(2014) J. C. Plana et al.   European Heart Journal-Cardiovascular Imaging

High-sensitivity troponin T as a marker to predict cardiotoxicity in breast cancer patients with adjuvant trastuzumab therapy

(2014) Kenichi Katsurada et al.   SpringerPlus

Review and Meta-Analysis of Incidence and Clinical Predictors of Anthracycline Cardiotoxicity

(2013) Marzia Lotrionte et al.   AMERICAN JOURNAL OF CARDIOLOGY

Remote Ischemic Preconditioning Improves Outcome at 6 Years After Elective Percutaneous Coronary Intervention

(2013) William R. Davies et al.   Circulation-Cardiovascular Interventions

Cardioprotective Effect of β-Adrenoceptor Blockade in Patients With Breast Cancer Undergoing Chemotherapy

(2013) Sinziana Seicean et al.   Circulation-Heart Failure

Molecular basis of cancer-therapy-induced cardiotoxicity: introducing microRNA biomarkers for early assessment of subclinical myocardial injury

(2013) Hardip Sandhu et al.   CLINICAL SCIENCE

Anthracycline-related cardiotoxicity in childhood cancer survivors

(2013) Steven E. Lipshultz et al.   CURRENT OPINION IN CARDIOLOGY

Myocardial reperfusion injury: looking beyond primary PCI

(2013) Georg M. Fröhlich et al.   EUROPEAN HEART JOURNAL

Improved long-term clinical outcomes in patients with ST-elevation myocardial infarction undergoing remote ischaemic conditioning as an adjunct to primary percutaneous coronary intervention

(2013) Astrid D. Sloth et al.   EUROPEAN HEART JOURNAL

Role of cardioprotective therapy for prevention of cardiotoxicity with chemotherapy: A systematic review and meta-analysis

(2013) Kashif Kalam et al.   EUROPEAN JOURNAL OF CANCER

Cardiovascular morbidity in long-term survivors of early-onset cancer: A population-based study

(2013) A.E. Kero et al.   INTERNATIONAL JOURNAL OF CANCER

Significance of High-Sensitivity Cardiac Troponin T in Hypertrophic Cardiomyopathy

(2013) Toru Kubo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mitochondrial Dysfunction as an Arrhythmogenic Substrate

(2013) David Montaigne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardioprotective and prognostic effects of remote ischaemic preconditioning in patients undergoing coronary artery bypass surgery: a single-centre randomised, double-blind, controlled trial

(2013) Matthias Thielmann et al.   LANCET

Oxidative Stress, Redox Signaling, and Metal Chelation in Anthracycline Cardiotoxicity and Pharmacological Cardioprotection

(2012) Martin Štěrba et al.   ANTIOXIDANTS & REDOX SIGNALING

Projections of cancer prevalence in the United Kingdom, 2010–2040

(2012) J Maddams et al.   BRITISH JOURNAL OF CANCER

Cancer treatment and survivorship statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Abstract LB-339: Cause of death in cancer survivors

(2012) Y. Ning et al.   CANCER RESEARCH

Third Universal Definition of Myocardial Infarction

(2012) Kristian Thygesen et al.   CIRCULATION

Protective effects of nebivolol against anthracycline-induced cardiomyopathy: A randomized control study

(2012) Mehmet G. Kaya et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Incident thromboembolism and heart failure associated with new-onset atrial fibrillation in cancer patients

(2012) Yu-feng Hu et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Effect of Statin Therapy on the Risk for Incident Heart Failure in Patients With Breast Cancer Receiving Anthracycline Chemotherapy

(2012) Sinziana Seicean et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Reproducibility of Echocardiographic Techniques for Sequential Assessment of Left Ventricular Ejection Fraction and Volumes

(2012) Paaladinesh Thavendiranathan et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Identification of the molecular basis of doxorubicin-induced cardiotoxicity

(2012) Sui Zhang et al.   NATURE MEDICINE

Doxorubicin induced myocardial injury is exacerbated following ischaemic stress via opening of the mitochondrial permeability transition pore

(2012) M. Gharanei et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Amelioration of doxorubicin-induced cardiotoxicity by deferiprone in rats

(2011) El-Sayed M. Ammar et al.   CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY

Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial

(2011) Derek J. Hausenloy et al.   Clinical Research in Cardiology

The therapeutic potential of ischemic conditioning: an update

(2011) Derek J. Hausenloy et al.   Nature Reviews Cardiology

The combination of high-sensitivity cardiac troponin T (hs-cTnT) at presentation and changes in N-terminal natriuretic peptide type B (NT-proBNP) after chemotherapy best predicts survival in AL amyloidosis

(2010) G. Palladini et al.   BLOOD

Cardioprotective Role of Remote Ischemic Periconditioning in Primary Percutaneous Coronary Intervention

(2010) Ilias Rentoukas et al.   JACC-Cardiovascular Interventions

Anthracycline-Induced Cardiomyopathy

(2010) Daniela Cardinale et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

(2010) Hans Erik Bøtker et al.   LANCET

Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial

(2010) Steven E Lipshultz et al.   LANCET ONCOLOGY

Doxorubicin induces mitochondrial permeability transition and contractile dysfunction in the human myocardium

(2010) David Montaigne et al.   MITOCHONDRION

Cardiotoxicity of anticancer treatments: what the cardiologist needs to know

(2010) Michael S. Ewer et al.   Nature Reviews Cardiology

Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study

(2009) Stephen P. Hoole et al.   CIRCULATION

Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics support

(2008) Paul A. Harris et al.   JOURNAL OF BIOMEDICAL INFORMATICS

Doxorubicin, Cardiac Risk Factors, and Cardiac Toxicity in Elderly Patients With Diffuse B-Cell Non-Hodgkin's Lymphoma

(2008) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY